Amanda Berger and Bridgette Tippin Davis look ahead at the refinements and advances coming to genetic testing for epilepsy.
-
Healthcare Providers
-
Frequently Ordered Tests
Frequently Ordered Tests
Choose a Disease Type
Use AmbryPort
Visit our secure online portal to start your order.
AmbryPort Login or Create an AccountAdditional Information
Delivering Accuracy
Confidently guiding patient care through reliable results
- Test Development
- Quality Control
- Confirmatory Testing
Bringing Clarity
Finding answers through superior variant interpretation
- Variant Assessment
- Ambry’s Translational Genomics (ATG) Lab
- Family Studies Program
Advancing Science
Understanding human disease through innovation, research, and partnerships
- History of Innovation
- Practice-Changing Research
- Precision Medicine
![]()
Offering anonymous, no-cost genetic testing and confidential genetic counseling to patients suspected of having or clinically diagnosed with hATTR amyloidosis through the hATTR Compass program
Choose an option below to order
your kit and start your genetic testingSelect a Form Type
Excellent Coverage, Personalized Support
Preverification
Will insurance cover my patient's genetic test?
Click HerePayor Relations
Why partner with us?
Learn MoreOur Resources
Welcome
Please select a menu option
![EducateNext]()
![Cardio Product Update]()
-
- Patients
-
Advancing Science
-
About
-
We are driven to give healthcare providers the most advanced testing information available so you can determine the best treatment options for your patients.
-
Subscribe To Our Future Research
Ambry Shares: What’s Next in Epilepsy Genetic Testing
Senior Product Manager, Neurology Ambry Genetics
Laboratory Technical Director Ambry Genetics
- Date: Tue, November 17, 2015
- Time: 10:00am PST
- Duration: 1 hour and 15 minutes
- C.E.U. --
- P.A.C.E. --
Webinar Newsletter
Subscribe to receive notifications for future webinars.
Subscribe